STOCK TITAN

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company specializing in data-driven medicine, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, before U.S. markets open.

The company will host a conference call to discuss the results and business outlook at 8:00 AM EDT / 2:00 PM CET. Investors can access the live webcast through the SOPHiA GENETICS Investor Relations Website, where a replay will also be available after the event.

SOPHiA GENETICS (Nasdaq: SOPH), azienda software nativa del cloud specializzata in medicina basata sui dati, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 5 agosto 2025, prima dell'apertura dei mercati statunitensi.

La società terrà una conference call per discutere i risultati e le prospettive aziendali alle 08:00 EDT / 14:00 CET. Gli investitori potranno seguire la diretta streaming tramite il sito web delle Relazioni con gli Investitori di SOPHiA GENETICS, dove sarà disponibile anche una registrazione dopo l'evento.

SOPHiA GENETICS (Nasdaq: SOPH), una empresa de software nativa en la nube especializada en medicina basada en datos, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 5 de agosto de 2025, antes de la apertura de los mercados en EE. UU.

La compañía realizará una llamada de conferencia para discutir los resultados y las perspectivas comerciales a las 8:00 AM EDT / 2:00 PM CET. Los inversores podrán acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores de SOPHiA GENETICS, donde también estará disponible una repetición después del evento.

SOPHiA GENETICS (나스닥: SOPH)는 데이터 기반 의학에 특화된 클라우드 네이티브 소프트웨어 회사로, 2025년 2분기 재무 실적 발표를 2025년 8월 5일 미국 시장 개장 전으로 예정했습니다.

회사는 동부 표준시 오전 8시 / 중앙유럽 시간 오후 2시에 실적 및 사업 전망에 대해 논의하는 컨퍼런스 콜을 개최할 예정입니다. 투자자들은 SOPHiA GENETICS 투자자 관계 웹사이트를 통해 라이브 웹캐스트에 접속할 수 있으며, 행사 후 다시보기 또한 제공됩니다.

SOPHiA GENETICS (Nasdaq : SOPH), une entreprise de logiciels cloud-native spécialisée dans la médecine basée sur les données, a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 5 août 2025, avant l'ouverture des marchés américains.

L'entreprise tiendra une conférence téléphonique pour discuter des résultats et des perspectives commerciales à 8h00 EDT / 14h00 CET. Les investisseurs pourront accéder à la diffusion en direct via le site des relations investisseurs de SOPHiA GENETICS, où un replay sera également disponible après l'événement.

SOPHiA GENETICS (Nasdaq: SOPH), ein cloud-natives Softwareunternehmen, das sich auf datengetriebene Medizin spezialisiert hat, hat die Veröffentlichung seiner Finanzergebnisse für das zweite Quartal 2025 für den 5. August 2025 vor Markteröffnung in den USA geplant.

Das Unternehmen wird eine Telefonkonferenz abhalten, um die Ergebnisse und die Geschäftsaussichten um 8:00 Uhr EDT / 14:00 Uhr MEZ zu besprechen. Investoren können über die Investor-Relations-Website von SOPHiA GENETICS auf das Live-Webcast zugreifen, wo auch eine Aufzeichnung nach der Veranstaltung verfügbar sein wird.

Positive
  • None.
Negative
  • None.

BOSTON and ROLLE, Switzerland, July 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the second quarter 2025 before U.S. markets open on Tuesday, August 5, 2025. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data – including genomics, radiomics, clinical, biological, and digital pathology data – to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-announce-financial-results-for-second-quarter-2025-on-august-5-2025-302509646.html

SOURCE SOPHiA GENETICS

FAQ

When will SOPHiA GENETICS (SOPH) release Q2 2025 earnings?

SOPHiA GENETICS will release its Q2 2025 financial results on Tuesday, August 5, 2025, before U.S. markets open.

What time is the SOPHiA GENETICS Q2 2025 earnings call?

The earnings conference call is scheduled for 8:00 AM EDT / 2:00 PM CET on August 5, 2025.

How can I access SOPHiA GENETICS (SOPH) Q2 2025 earnings call?

The call will be available via live webcast on the SOPHiA GENETICS Investor Relations Website. A replay will also be available after the call.

What will SOPHiA GENETICS discuss in their Q2 2025 earnings call?

The company will discuss their Q2 2025 financial results and business outlook during the conference call.
Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

231.20M
62.47M
6.53%
54.32%
0.09%
Health Information Services
Healthcare
Link
Switzerland
Rolle